Also from this source


May 25, 2017, 06:00 ET RepliCel CEO Provides Company Outlook

You just read:

United States Patent Issued to RepliCel for its Novel Dermal Injection Technologies

News provided by

RepliCel Life Sciences Inc.

Apr 25, 2017, 06:00 ET